Zika in Belgium
Joint symposium
BVIKM-SBIMC & WIV-ISP
19/5/2016
Marjan Van Esbroeck
• Epidemiology
• Transmission
• Clinical symptoms
• Laboratory diagnosis
2
Outline
Epidemiology
3
Petersen LR et al. Zika Virus. NEJM. 2016 Apr 21;374(16):1552-63.
Outbreaks Sporadic cases
Environmental suitability for Zika virus
4
Messina JP, et al. Mapping global environmental suitability for Zika virus. Elife. 2016 Apr 19;5. pii: e15272
Status of ZIKV reporting as of 2016 by country, showing countries that are highly environmentally suitable (having a suitable area of more than 10,000 square kilometres) but which have not yet reported symptomatic cases of ZIKV in humans. “Currently reporting” countries are those having reported cases since 2015.
Distribution of the vector USA / Europe
5
Belgium: 18 cases (17 confirmed)
6
ZIKV in Europe
Transmission
7
Rodriguez-Morales et al., Ann Clin Microb Antimicrobials 2016
Symptoms
8
Duffy MR et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. NEJM 2009; 360: 2536-43.
Zika virus (ZIKV)
9
Flavivirus enveloped pos. sense ss RNA virus, genome of 11 kbp
ELISA PCR
Zika virus (ZIKV)
10
Musso (2016) Clin Microbiol Rev
Laboratory diagnosis
11
stay incubation development of Ab
max. 12 days 1 week
Symptomatic PCR+ serology
Asymptomatic Serology 3 w after return
Pregnancy/wish (partner) repeat serology if neg.
Laboratory diagnosis
12
http://ecdc.europa.eu/en/publications/Publications/zika-virus-guidance-healthcare-providers-and-laboratory-diagnosis.pdf
13
ZIKV PCR
Reference imported in returning from days sample ZIKA RT-PCR flavi RT-PCR ZIKV IFFA
Tappe et al., 2014 Italy Thailand 10d serum neg neg pos
31d serum ND ND pos
67d serum ND ND pos
Tappe et al. 2014 Germany Borneo 3d serum neg ND neg
6d serum ND ND pos
11d serum ND ND pos
Waehre et al., 2014 Norway Tahiti 5d serum pos neg neg
36d serum neg ND pos
Zammarchi et al., 2015 Italy Brazil 3d serum neg neg pos
17d serum neg neg pos
Zammarchi et al., 2015 Italy French-Polynesia 3d serum pos ND neg
35d serum ND ND pos
62d serum ND ND pos
3d serum neg ND neg
33d serum ND ND pos
62d serum ND ND pos
Malvy 2015 (Promed) France Martinique 7d serum + urine pos ND ND
Goorhuis 2015 (Promed) the Netherlands Suriname 3d serum pos ND ND
Korhonen et al., 2016 Finland Madives 8d serum ND neg ND
9d urine ND pos ND
Case reported here Belgium Guatemala 3d serum pos pos neg
17d serum ND ND pos
Viremia in pregnant women
14
Driggers RW et al. Zika Virus Infection with Prolonged Maternal Viremia and Fetal Brain Abnormalities. NEJM. 2016 Mar 30.
4 weeks POS 10 weeks POS
ZIKV RNA in urine
15
Gourinat et al. Detection of Zika virus in urine. Emerg Infect Dis. 2015 Jan;21(1):84-6.
ZIKV RNA in urine
16
Bingham AM et al. Comparison of Test Results for Zika Virus RNA in Urine, Serum, and Saliva Specimens from Persons with Travel-Associated Zika Virus Disease — Florida, 2016. MMWR; Early Release. Vol. 65 May 10, 2016
70 ZIKV-patients
time after Ʃ onset urine serum
≤ 5 days 52/55 (95%) 31/55 (56%)
> 5 (max. 20) 9/11 (82%) 0/11 (0%)
RT-PCR
17
ZIKV in Belgium
Number of requests for lab diagnosis
week
Number of requests for PCR on sperm
Federal Agency for Medicine and Health Products
Exclusion
Asymptomatic sperm donor
Sperm donor diagnosed with zika
6 months after return OR neg. NAT in sperm
Transplantation of tissue/cell/ organ/gamete/embryo
Exclusion
Asymptomatic donor
4 weeks after return OR neg. NAT in blood
Donor diagnosed with zika
4 weeks after recovery
Donor with male sexual partner diagnosed with zika or stay in endemic area < 6 months before
4 weeks after last sexual contact OR neg. NAT in blood
Quality/safety/efficacy of medicinal products for human use
18
Specificity of ZIKV ELISA
19
Huzly et al. High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill. 2016 21 (16).
20
Virus neutralization test
• Low/short viremia
• Extend diagnostic window – PCR on urine/semen
• Rapid decrease in IgM antibodies
Importance pregnancy
wish to become pregnant
Does semen becomes always positive?
If yes when?
Also in asymptomatic men?
21
Conclusions
Acknowledgements Lieselotte Cnops Dorien van den Bossche Kevin Ariën Jacob Verschueren Kathleen Meersman Ralph Huits Ula Maniewski-Kelner Lab personnel ITM
www.itg.be